Skip to content
Search

Latest Stories

Fake Ozempic and Saxenda pens found in the UK

MHRA has seized the injections sold through ‘non-legitimate’ routes

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned the public to avoid buying pre-filled weight loss pens without a prescription.


The warning came after 369 fake Ozempic injections have been seized since January 2023.

However, Saxenda pens were obtained by members of the public in the UK through "non-legitimate routes".

The health regulator has urged the public to buy the pens after consulting a healthcare professional and with a prescription.

Dr Alison Cave, MHRA Chief Safety Officer shared her opinion on the matter, she said: “Buying products such as Ozempic or Saxenda without a prescription, from illegally trading suppliers, significantly increases the risk of receiving something which is either fake or not licensed for use in the UK.

“Products purchased in this way do not meet our strict quality and safety standards, and taking such medicines may put your health at significant risk.

She added: “We are advising all members of the public not to use any pre-filled weight loss pens they may have bought online and instead to report it to us so that we can investigate and take any necessary action.”

saxenda Saxenda is used for weight loss with diet and exercise. Credit: iStock

Since, the active pharmaceutical ingredient (API) found in the pens, Semaglutide and Liraglutide are prescription-only medicines.

The Ozempic is authorised in the UK for the treatment of adults with type 2 diabetes, while Saxenda is used for weight loss with diet and exercise.

However, Ozempic is commonly used off-label for weight loss in the UK.

Health Minister Will Quince said: “No one should put profit before the needs of patients, but fraudsters selling black market medicines like this are extremely dangerous and can put people’s health at risk.

“The medical advice is clear: patients should only use medicines like Ozempic or Saxenda where they’ve been prescribed it by a legitimate source, such as their GP or another legitimate prescriber.

“The MHRA have our full support in cracking down on these illegal online suppliers to ensure that patients are protected.”

MHRA confirmed that Ozempic had been found at two UK wholesalers on 18 October.

Last week, several Austrians were taken to the hospital after injecting fake Ozempic but the number of hospitalisations in the UK is still unknown.

Austria’s Federal Office for Safety in Health Care (BASG) confirmed that the patients have suffered hypoglycaemia shock, coma, and seizures.

It is believed that the injections contained insulin instead of the weight loss drug, semaglutide.

The surge in the sale of fake Ozempic has been flagged by the drug’s Danish manufacturer, Novo Nordisk.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less